Skip to content

13F-HR filed by Cubist Systematic Strategies, LLC

Cubist Systematic Strategies, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 3,533 holding rows worth $11,848,690,000.

Accession
0001567619-22-010951
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 3,533 entries on the cover page, a total value of $11,848,690,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $11,848,690,000 with VALUE read as thousands by filing date, 13F file number 028-16258. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AST SPACEMOBILE INC COM CL A00217D100Stock770$8,000thousands by filing date
BRAZE INC10576N102COM CL A200$8,000thousands by filing date
EPIZYME INC29428V104COM7,200$8,000thousands by filing date
VIGIL NEUROSCIENCE INC92673K108COM1,000$7,000thousands by filing date
APTINYX INC03836N103COM2,700$6,000thousands by filing date
ANAPTYSBIO INC032724106COM213$5,000thousands by filing date
CLIMB BIO INC28658R106COMMON STOCK638$5,000thousands by filing date
Ohr Pharmaceutical Inc64132K102COM2,525$5,000thousands by filing date
IQIYI INC SPONSORED ADS46267X108ADR871$4,000thousands by filing date
TERNS PHARMACEUTICALS INC COM880881107Stock1,200$4,000thousands by filing date
LI-CYCLE HOLDINGS CORP50202P105COMMON SHARES400$3,000thousands by filing date
AVALO THERAPEUTICS INC05338F108CMN3,764$3,000thousands by filing date
VERISK ANALYTICS INC COM92345Y106Stock7$2,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock37$2,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM1,400$2,000thousands by filing date
ACHILLES THERAPEUTICS PL-ADR00449L102COM585$2,000thousands by filing date
Merrimack Pharmaceuticals Inc590328209Common / Ordinary Stock368$2,000thousands by filing date
PROSPECTOR CAPITAL CORPG7273A105COM200$2,000thousands by filing date
AFFIMED N VN01045108COM439$2,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM90$1,000thousands by filing date
TRAEGER INC89269P103COMMON STOCK100$1,000thousands by filing date
GENOCEA BIOSCIENCES INC372427401COMMON STOCK900$1,000thousands by filing date
HIGHLAND TRANSCEND PARTNERSG44690108COM CL A100$1,000thousands by filing date
NEUROPACE INC641288105COMMON STOCK18$0thousands by filing dateValue filed as zero, left out of ratios.
LAVA THERAPEUTICS NVN51517105SHS101$0thousands by filing dateValue filed as zero, left out of ratios.
Ventyx Biosciences Inc92332V107Common Stock26$0thousands by filing dateValue filed as zero, left out of ratios.
IMMUNIC INC4525EP101COM44$0thousands by filing dateValue filed as zero, left out of ratios.
THERAPEUTICSMD INC88338N107COM1,034$0thousands by filing dateValue filed as zero, left out of ratios.
9 METERS BIOPHARMA INC654405109COM600$0thousands by filing dateValue filed as zero, left out of ratios.
F-STAR THERAPEUTICS INC30315R107COM66$0thousands by filing dateValue filed as zero, left out of ratios.
MOGO INC60800C109COM100$0thousands by filing dateValue filed as zero, left out of ratios.
CYCLACEL PHARMACE 6percent PFDCONV23254L603Stock2$0thousands by filing dateValue filed as zero, left out of ratios.
FIELD TRIP HEALTH LTD31656R102COM337$0thousands by filing dateValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-010951this filing2022-05-16acceptance time not in the bulk data set